Targeted treatment for fragile X syndrome: results of a randomized controlled phase II trial of arbaclofen

被引：0
|
作者：
Hagerman, Randi [1 ,2 ]
Rathmell, Barbara [3 ]
Wang, Lulu [1 ,2 ]
Carpenter, Randy [3 ]
Wang, Paul [3 ]
Berry-Kravis, Elizabeth [4 ]
机构：
[1] UC Davis Med Ctr, MIND Inst, Sacramento, CA USA
[2] UC Davis Med Ctr, Dept Pediat, Sacramento, CA USA
[3] Seaside Therapeut, Boston, MA USA
[4] Rush Univ, Med Ctr, Dept Neurol, Chicago, IL 60612 USA
来源：
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH | 2010年 / 54卷
关键词：
fragile X syndrome; targeted treatments; GABA; arbaclofen;
D O I：
暂无
中图分类号：
G76 [特殊教育];
学科分类号：
040109 ;
摘要：
引用
收藏
页码：884 / 884
页数：1
相关论文
共 50 条
  • [1] Arbaclofen in fragile X syndrome: results of phase 3 trials
    Elizabeth Berry-Kravis
    Randi Hagerman
    Jeannie Visootsak
    Dejan Budimirovic
    Walter E. Kaufmann
    Maryann Cherubini
    Peter Zarevics
    Karen Walton-Bowen
    Paul Wang
    Mark F. Bear
    Randall L. Carpenter
    Journal of Neurodevelopmental Disorders, 2017, 9
  • [2] Arbaclofen in fragile X syndrome: results of phase 3 trials
    Berry-Kravis, Elizabeth
    Hagerman, Randi
    Visootsak, Jeannie
    Budimirovic, Dejan
    Kaufmann, Walter E.
    Cherubini, Maryann
    Zarevics, Peter
    Walton-Bowen, Karen
    Wang, Paul
    Bear, Mark F.
    Carpenter, Randall L.
    JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2017, 9
  • [3] Phase II and III drugs for the treatment of fragile X syndrome
    Politte, Laura C.
    McDougle, Christopher J.
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (01): : 47 - 65
  • [4] Metformin as targeted treatment in fragile X syndrome
    Dy, A. B. C.
    Tassone, F.
    Eldeeb, M.
    Salcedo-Arellano, M. J.
    Tartaglia, N.
    Hagerman, R.
    CLINICAL GENETICS, 2018, 93 (02) : 216 - 222
  • [5] Targeted treatments in fragile X syndrome
    Hare, Emma B.
    Hagerman, Randi J.
    Lozano, Reymundo
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (06): : 531 - 543
  • [6] Telehealth-enabled behavioral treatment for problem behaviors in boys with fragile X syndrome: a randomized controlled trial
    Hall, Scott S.
    Monlux, Katerina D.
    Rodriguez, Arlette Bujanda
    Jo, Booil
    Pollard, Joy S.
    JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2020, 12 (01)
  • [7] Telehealth-enabled behavioral treatment for problem behaviors in boys with fragile X syndrome: a randomized controlled trial
    Scott S. Hall
    Katerina D. Monlux
    Arlette Bujanda Rodriguez
    Booil Jo
    Joy S. Pollard
    Journal of Neurodevelopmental Disorders, 2020, 12
  • [8] Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial
    Veenstra-VanderWeele, Jeremy
    Cook, Edwin H.
    King, Bryan H.
    Zarevics, Peter
    Cherubini, Maryann
    Walton-Bowen, Karen
    Bear, Mark F.
    Wang, Paul P.
    Carpenter, Randall L.
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 (07) : 1390 - 1398
  • [9] A combination of ascorbic acid and α-tocopherol to test the effectiveness and safety in the fragile X syndrome: study protocol for a phase II, randomized, placebo-controlled trial
    de Diego-Otero, Yolanda
    Calvo-Medina, Rocio
    Quintero-Navarro, Carolina
    Sanchez-Salido, Lourdes
    Garcia-Guirado, Francisco
    del Arco-Herrera, Ignacio
    Fernandez-Carvajal, Isabel
    Ferrando-Lucas, Teresa
    Caballero-Andaluz, Rafaela
    Perez-Costillas, Lucia
    TRIALS, 2014, 15
  • [10] A combination of ascorbic acid and α-tocopherol to test the effectiveness and safety in the fragile X syndrome: study protocol for a phase II, randomized, placebo-controlled trial
    Yolanda de Diego-Otero
    Rocio Calvo-Medina
    Carolina Quintero-Navarro
    Lourdes Sánchez-Salido
    Francisco García-Guirado
    Ignacio del Arco-Herrera
    Isabel Fernández-Carvajal
    Teresa Ferrando-Lucas
    Rafaela Caballero-Andaluz
    Lucia Pérez-Costillas
    Trials, 15
12345